Related Experiment Video
Updated: Feb 25, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
L-3-n-Butylphthalide Protects HSPB8 K141N Mutation-Induced Oxidative Stress by Modulating the Mitochondrial Apoptotic
Xiao-Dong Yang1,2, Zhi-Dong Cen1, Hai-Peng Cheng3
1Department of Neurology, The Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHangzhou, China.
Abstract:
Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathy, is the most common inherited peripheral nerve disorder. Missense mutations, such as K141N, in the small heat shock protein HSPB8 are known to cause distal hereditary motor neuropathy 2A (dHMN2A) or Charcot-Marie-Tooth neuropathy type 2L (CMT2L). However, of critical clinical significance, very few specific therapies for this disease exist. In the present study, we investigated the impact of mutant K141N HSPB8 on mitochondrial distribution and function in a cellular model of CMT2L. Our results indicate that K141N HSPB8 induced mitochondrial aggregation and caused increased oxidative stress injury. As an extraction from Chinese celery Apium graveolens Linn seeds, L-3-n-Butylphthalide (NBP), has been reported to exert many neuroprotective effects, we interrogated whether NBP could elicit a protective effect on the cell injury typically caused by HSPB8 K141N mutations. We found NBP could reverse the pathological processes induced by HSPB8 K141N mutation via an antioxidant effect, modulation of the Bax/Bcl-2 mitochondrial apoptotic and Nrf2 pathways. We propose a novel function of HSPB8, highlighting the consequence of the K141N pathogenic mutation. Furthermore, we suggest NBP may have promising therapeutic potential in the treatment of CMT2L.
Insights
L-3-n-Butylphthalide (NBP) shows therapeutic potential for Charcot-Marie-Tooth disease type 2L (CMT2L). NBP reverses mitochondrial dysfunction and oxidative stress caused by HSPB8 K141N mutations, offering a promising treatment avenue.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Charcot-Marie-Tooth disease (CMT) is a common inherited peripheral nerve disorder.
- Specific mutations in HSPB8, like K141N, cause CMT type 2L (CMT2L), a debilitating condition with limited therapeutic options.
Purpose of the Study:
- To investigate the effects of the K141N HSPB8 mutation on mitochondrial function in a cellular model of CMT2L.
- To evaluate the potential neuroprotective effects of L-3-n-Butylphthalide (NBP) against HSPB8 K141N-induced cellular damage.
Main Methods:
- Utilized a cellular model expressing mutant K141N HSPB8.
- Assessed mitochondrial distribution and function.
- Investigated the impact of NBP on oxidative stress, apoptosis (Bax/Bcl-2 pathway), and Nrf2 signaling.
Main Results:
- Mutant K141N HSPB8 induced mitochondrial aggregation and increased oxidative stress.
- NBP treatment reversed these pathological changes.
- NBP demonstrated antioxidant effects and modulated mitochondrial apoptotic and Nrf2 pathways.
Conclusions:
- The K141N mutation in HSPB8 disrupts mitochondrial homeostasis and exacerbates oxidative stress.
- NBP exhibits significant neuroprotective properties against CMT2L-associated cellular damage.
- NBP presents a promising therapeutic candidate for treating Charcot-Marie-Tooth disease type 2L.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Intrinsic Apoptotic Pathway
